Soleil Securities Group lowers its price target on Arena Pharmaceuticals (Nasdaq: ARNA) from $20 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE